The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Spring 2025 RFA: Molecular MRI Biomarker Program, 2026Exploring Dynamic Brain Metabolism in PD
Study Rationale:
Existing non-invasive imaging methods can only measure steady-state metabolic concentrations. There is a need to more precisely dynamic measure brain metabolite...
-
Research Grant, 2026Discovery of Selective PET Imaging Agents for Alpha-Synuclein
-
Research Grant, 2026Discovery of Selective PET Imaging Agents for Tauopathies
Study Rationale:
Assessing the accumulation of tau proteins in living human brain is crucial to better understand the pathophysiology of Progressive Supranuclear Palsy (PSP)...
-
Summer 2025 RFP: Accelerating Biological Understanding and Translational Approaches for PD Program - Biomarkers, 2026Dried Blood Spot Based Biomarkers
Study Rationale:
Changes in the GBA1 gene are the most common known genetic risk factor for Parkinson’s disease (PD). This gene encodes the enzyme glucocerebrosidase (GCase), which...
-
Research Grant, 2026Neuroimmune Assay Workstream Validation
Study Rationale:
This project will standardize common biological assays to provide reproducible results related to immune cell function for patients with Parkinson’s Disease (PD)...
-
, 2026An AMP-PD Resource of Allele Calls for Polymorphic Determinants of Immune Function
Study Rationale:
The immune system plays a complex role in Parkinson’s disease (PD), sometimes protecting the brain and other times accelerating damage. Two specific families of...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.